Covered recipient · General Payments record
NEVINE AWAD
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Adult Health
General Payments · PY2021–2024
$1,134.88
- Reported across 54 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $683.87 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $212.67 | 7 |
| Acerta Pharma LLC | $177.71 | 3 |
| Novo Nordisk AS | $86.49 | 5 |
| GlaxoSmithKline, LLC. | $84.13 | 5 |
| ABBVIE INC. | $54.70 | 3 |
| PFIZER INC. | $20.24 | 1 |
| Xeris Pharmaceuticals, Inc. | $19.38 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $15.03 | 1 |
| EISAI INC. | $13.52 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.20 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106463670 | CMS |
| ABBVIE INC. | $18.57 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106463672 | CMS |
| ABBVIE INC. | $18.93 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106463674 | CMS |
| Amgen Inc. | $16.71 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117498430 | CMS |
| Amgen Inc. | $124.98 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117498440 | CMS |
| Amgen Inc. | $13.18 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117498432 | CMS |
| Amgen Inc. | $15.00 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117498434 | CMS |
| Amgen Inc. | $17.07 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117498436 | CMS |
| Amgen Inc. | $16.93 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117498438 | CMS |
| Amgen Inc. | $8.80 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117194200 | CMS |
| AstraZeneca Pharmaceuticals LP | $53.66 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104256125 | CMS |
| AstraZeneca Pharmaceuticals LP | $106.20 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104260715 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.85 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105824089 | CMS |
| Eisai Inc. | $13.52 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110816880 | CMS |
| GlaxoSmithKline, LLC. | $15.15 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116441007 | CMS |
| GlaxoSmithKline, LLC. | $16.69 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116331294 | CMS |
| GlaxoSmithKline, LLC. | $16.87 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116305869 | CMS |
| GlaxoSmithKline, LLC. | $17.00 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115764508 | CMS |
| GlaxoSmithKline, LLC. | $18.42 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116597669 | CMS |
| Novartis Pharmaceuticals Corporation | $15.03 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086762149 | CMS |
| Novo Nordisk Inc | $16.06 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100414011 | CMS |
| Novo Nordisk Inc | $15.82 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100627814 | CMS |
| Novo Nordisk Inc | $16.49 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100347742 | CMS |
| Novo Nordisk Inc | $16.67 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100380155 | CMS |
| Novo Nordisk Inc | $21.45 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100352510 | CMS |
| PFIZER INC. | $20.24 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131027859 | CMS |
| Xeris Pharmaceuticals, Inc. | $19.38 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144635998 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.